Adult ADHD has been recognized as a substantial public health issue with recent CDC data. Per the CDC Morbidity and Mortality Weekly Report (October 2024) — the CDC’s first major update on adult ADHD in nearly 20 years — approximately 6.0% of U.S. adults (about 15.5 million people) currently have an ADHD diagnosis.
Strikingly, more than half (55.9%) of adults with current ADHD diagnosis received that diagnosis in adulthood — meaning much of adult ADHD doesn’t fit the childhood-diagnosis pattern many people associate with the condition.
DSM-5-TR Adult ADHD Criteria
ADHD in adults requires:
- 5 or more symptoms of inattention OR hyperactivity-impulsivity (6+ for children), present for at least 6 months
- Several symptoms present before age 12
- Symptoms present in two or more settings
- Clear evidence of significant impairment
- Symptoms not better explained by another mental disorder
Inattention symptoms
- Difficulty sustaining attention
- Doesn’t seem to listen when spoken to directly
- Difficulty following through on instructions/tasks
- Difficulty organizing tasks
- Avoids tasks requiring sustained mental effort
- Loses things
- Easily distracted
- Forgetful in daily activities
- Difficulty paying attention to details / careless mistakes
Hyperactivity-impulsivity symptoms
- Restlessness, fidgeting
- Difficulty staying seated
- Inner restlessness (common in adults vs visible hyperactivity)
- Difficulty engaging in leisure quietly
- “On the go,” driven by motor
- Talks excessively
- Blurts out answers
- Difficulty waiting turn
- Interrupts/intrudes
Adult ADHD Looks Different Than Childhood ADHD
Hyperactivity in adults often manifests as:
- Internal restlessness rather than visible movement
- Difficulty relaxing
- Mental hyperactivity — racing thoughts, jumping between topics
- Workaholism, multiple simultaneous projects
- Talking excessively
- Fidgeting, foot-tapping rather than running around
Inattention in adults shows up as:
- Time blindness
- Difficulty with paperwork, taxes, administrative tasks
- Forgetting appointments, deadlines
- Difficulty completing long-term projects
- “Wallpaper effect” — important things blending into environment
- Difficulty during phone calls, meetings, reading
- Career underperformance relative to apparent capability
Common Functional Impacts
- Career underachievement relative to ability
- Job loss or job changes
- Relationship difficulties (chronic lateness, forgotten commitments, emotional dysregulation)
- Financial difficulties (impulsive spending, late bills, tax problems)
- Educational underperformance
- Substance use (self-medication common)
- Driving issues — risk for accidents higher than non-ADHD population per published research
- Reduced self-esteem from years of underperformance
Common Comorbidities
Adult ADHD frequently coexists with:
- Anxiety disorders (25-50% of adults with ADHD)
- Depression
- Substance use disorders
- Learning disabilities
- Sleep disorders
- Bipolar disorder (sometimes)
Why Adult Diagnosis Is Often Delayed
- Childhood ADHD missed — particularly in girls, who often have inattentive presentation without disruptive behavior
- Coping strategies and high intelligence mask symptoms until demands exceed capacity
- College or career transition reveals underlying difficulties
- Parenthood reveals patterns
- Initial mental health treatment focuses on coexisting anxiety/depression without recognizing ADHD
Per CDC MMWR data, women in particular often receive ADHD diagnosis in adulthood after years of anxiety or depression treatment that didn’t fully resolve their difficulties.
Evidence-Based Treatment
Stimulant medications
Per the major 2018 Lancet Psychiatry network meta-analysis (Cortese et al.):
- Amphetamines recommended as first-line for adults with ADHD based on efficacy and acceptability
- Both amphetamine and methylphenidate produce substantial effect sizes (>0.8) relative to non-stimulant medications (~0.6)
- Long-acting formulations preferred over short-acting
- Approximately 71% of patients respond to methylphenidate; 68% to amphetamines; ~91% respond to at least one when both classes tried
Common stimulant medications: methylphenidate (Ritalin, Concerta), dexmethylphenidate (Focalin), amphetamine-dextroamphetamine (Adderall, Mydayis), lisdexamfetamine (Vyvanse).
Non-stimulant medications
- Atomoxetine (Strattera) — Selective norepinephrine reuptake inhibitor
- Guanfacine extended-release (Intuniv)
- Clonidine extended-release (Kapvay)
- Viloxazine (Qelbree)
Therapy and coaching
- CBT adapted for ADHD
- ADHD coaching for executive function skill building
- Couples therapy when relationship impact significant
Lifestyle factors
- Exercise (substantial evidence)
- Sleep optimization (sleep deprivation worsens ADHD symptoms)
- Organization and environmental design
- Technology tools (timers, reminders, capture systems)
Source: CDC MMWR (October 2024); Staley et al.
Late diagnosis
Many adults — particularly women — spend decades with undiagnosed ADHD, attributing difficulties to character flaws rather than treatable neurodevelopmental condition.
Comprehensive adult ADHD evaluation
Dr. Farkas provides specialist adult ADHD evaluation — including assessment of comorbidities and differential diagnosis.
Substantial improvement
Most adults with ADHD experience substantial improvement with evidence-based treatment.
Common Questions About Adult ADHD
Can I have ADHD if I wasn’t diagnosed as a child?
Yes — per CDC data, 55.9% of adults with current ADHD diagnosis received that diagnosis in adulthood. DSM-5-TR requires “several symptoms present before age 12” but not childhood diagnosis. Many adults — particularly women — had ADHD that was missed in childhood.
Are stimulants safe long-term?
When prescribed and monitored appropriately, stimulants are well-tolerated for most adults. They’re among the most-studied psychiatric medications. Periodic monitoring of blood pressure, cardiovascular factors, and effectiveness is standard.
Will stimulants make me feel high?
When dosed therapeutically, stimulants typically produce focus and clarity rather than euphoria in patients with ADHD. Therapeutic oral dosing of long-acting formulations differs substantially from misuse patterns. See our related articles on ADHD stimulants and women and ADHD.
What if I can’t get stimulants?
Non-stimulant options exist with substantial evidence — atomoxetine, guanfacine, clonidine, viloxazine. They work somewhat differently and may take longer to show effect, but represent legitimate alternatives.